AXIM Biotechnologies, Inc.

Biotechnology • Healthcare • San Diego, CA, United States • AXIM (PNK)

AXIM Biotechnologies, Inc. develops diagnostic healthcare solutions for ophthalmological conditions. It develops and commercializes two point-of-care diagnostic tests to assist eye-care physicians in detecting and quantifying biomarkers associated with aqueous deficient dry eye disease and non-specific allergic conjunctivitis, including ocular total immunoglobulin E allergy test and lactoferrin ADDE test. It also operates a full-service center for custom biomarker and biopharmaceutical research, custom assay development, clinical sample testing, and precision data delivery. In addition, the company develops a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring, as well as COVID-19 rapid diagnostic tools. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

AXIM Biotechnologies Announces Exclusive Latin America License & Distribution Agreement With JK Medical for TearScan(R) Ocular Diagnostic Tests - Yahoo Finance

Yahoo Finance • Oct 7

Axim Biotechnologies Files Pre-Submission With FDA for CLIA Waiver Pathway on Lactoferrin Point-of-Care Diagnostic Test - Yahoo Finance

Yahoo Finance • Jun 24

Check out 's stock price (AXIM) in real time - CNBC

CNBC • Sep 17

AXIM Biotechnologies, Inc. Announces Exclusive Distribution Agreement With VisionPlus Corp. for TearScan(R) Lactoferrin and IgE Diagnostic Tests in South Korea - Yahoo Finance

Yahoo Finance • Oct 23

AXIM Stock Price and Chart — OTC:AXIM - TradingView — Track All Markets

TradingView — Track All Markets • Jul 21

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has AXIM BIOTECHNOLOGIES, INC. had layoffs?

No layoff events have been recorded for AXIM BIOTECHNOLOGIES, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does AXIM BIOTECHNOLOGIES, INC. have?

AXIM BIOTECHNOLOGIES, INC. has approximately 6 employees.

What industry is AXIM BIOTECHNOLOGIES, INC. in?

AXIM BIOTECHNOLOGIES, INC. operates in the Biotechnology industry, within the Healthcare sector.

Is AXIM BIOTECHNOLOGIES, INC. a publicly traded company?

Yes, AXIM BIOTECHNOLOGIES, INC. is publicly traded under the ticker symbol AXIM on the PNK. The company has a market capitalization of approximately $0.00 billion.

Where is AXIM BIOTECHNOLOGIES, INC. headquartered?

AXIM BIOTECHNOLOGIES, INC. is headquartered in San Diego, CA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.